Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal

Código QR

Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal

Tomoyuki Kashima,1 Hirotaka Itakura,1,2 Hideo Akiyama,1 Shoji Kishi11Department of Ophthalmology, Gunma University, School of Medicine, Maebashi, Gunma, Japan; 2Department of Ophthalmology, Maebashi Red Cross Hospital, Maebashi, Gunma, JapanAbstract: Rebamipide was initially developed and approved...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kashima T, Itakura H, Akiyama H, Kishi S
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/0476d7810ae346dc877d11c0e16a3793
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Topical rebamipide improves lid wiper epitheliopathy
por: Itakura H, et al.
Publicado: (2013)

Topical rebamipide improves the ocular surface in mild lagophthalmos
por: Itakura M, et al.
Publicado: (2013)

Evaluation of dacryocystorhinostomy using optical coherence tomography and rebamipide ophthalmic suspension
por: Fujimoto M, et al.
Publicado: (2014)

Resolution of persistent corneal erosion after administration of topical rebamipide
por: Kashima T, et al.
Publicado: (2012)

Asymmetric severity of diabetic retinopathy in Waardenburg syndrome
por: Kashima T, et al.
Publicado: (2011)

Review of hydroxypropyl cellulose ophthalmic inserts for treatment of dry eye
por: Nguyen T, et al.
Publicado: (2011)

Critical appraisal of ophthalmic ketorolac in treatment of pain and inflammation following cataract surgery
por: Reddy RK, et al.
Publicado: (2011)

Clinical utility of 3% diquafosol ophthalmic solution in the treatment of dry eyes
por: Koh S
Publicado: (2015)

Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension
por: Bruce I Gaynes, et al.
Publicado: (2008)

Critical appraisal of loteprednol ointment, gel, and suspension in the treatment of postoperative inflammation and pain following ocular and corneal transplant surgery
por: Pirouzian A, et al.
Publicado: (2014)

Update and critical appraisal of the use of topical azithromycin ophthalmic 1% (AzaSite&reg;) solution in the treatment of ocular infections
por: Utine CA
Publicado: (2011)

Improved subjective symptoms of conjunctivochalasis using bipolar diathermy method for conjunctival shrinkage
por: Kashima T, et al.
Publicado: (2011)

Besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis patients with Pseudomonas aeruginosa infections
por: Silverstein BE, et al.
Publicado: (2012)

Dose uniformity of loteprednol etabonate ophthalmic gel (0.5%) compared with branded and generic prednisolone acetate ophthalmic suspension (1%)
por: Marlowe ZT, et al.
Publicado: (2013)

Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections
por: Darlene Miller
Publicado: (2008)

Safety and efficacy of MIM D3 ophthalmic solutions in a randomized placebo controlled Phase 2 clinical trial in patients with dry eye
por: Meerovitch K, et al.
Publicado: (2013)

The relationship between Graves’ ophthalmopathy and dry eye syndrome
por: Selter JH, et al.
Publicado: (2014)

An evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye
por: Ousler III G, et al.
Publicado: (2015)

Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension
por: Michele Iester
Publicado: (2008)

Dose uniformity of topical corticosteroid preparations: difluprednate ophthalmic emulsion 0.05% versus branded and generic prednisolone acetate ophthalmic suspension 1%
por: William Stringer, et al.
Publicado: (2010)

Critical appraisal of ranibizumab in the treatment of diabetic macular edema
por: Stewart MW
Publicado: (2013)

Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis
por: Daoud Al-Badriyeh, et al.
Publicado: (2010)

Etiology, prevalence, and treatment of dry eye disease
por: Johnny L Gayton
Publicado: (2009)

Treatment of chronic dry eye: focus on cyclosporine
por: George D Kymionis, et al.
Publicado: (2008)

Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis
por: Jeremy B Wingard, et al.
Publicado: (2011)

Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomes
por: Morris TW, et al.
Publicado: (2011)

The challenge of dry eye diagnosis
por: Giacomo Savini, et al.
Publicado: (2008)

Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease
por: de Oliveira RC, et al.
Publicado: (2019)

Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye
por: Deveney T, et al.
Publicado: (2018)

Safety of besifloxacin ophthalmic suspension 0.6% in refractive surgery: a retrospective chart review of post-LASIK patients
por: Nielsen SA, et al.
Publicado: (2013)

Safety of besifloxacin ophthalmic suspension 0.6% in refractive surgery: a retrospective chart review of post-LASIK patients
por: Nielsen SA, et al.
Publicado: (2013)

Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye
por: White DE, et al.
Publicado: (2019)

Efficacy of retinol palmitate eye drops for dry eye in rabbits with lacrimal gland resection
por: Odaka A, et al.
Publicado: (2012)

Changes in Tear Proteome After Acupuncture Treatment in Dry Eye
por: Tong L, et al.
Publicado: (2021)

Ophthalmic manifestations of children with Down syndrome in Port Harcourt, Nigeria
por: Adio AO, et al.
Publicado: (2012)

Managing Sjögren’s Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy
por: Coursey TG, et al.
Publicado: (2014)

PERSIST: Physician&#39;s Evaluation of Restasis&reg; Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review
por: Mah F, et al.
Publicado: (2012)

Prolonged increase in tear meniscus height by 3% diquafosol ophthalmic solution in eyes with contact lenses
por: Nagahara Y, et al.
Publicado: (2015)

Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: etiology of bacterial conjunctivitis and antibacterial susceptibility profile
por: Haas W, et al.
Publicado: (2011)

Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE™) model
por: Sosne G, et al.
Publicado: (2015)